CAIRO: Sovaldi, the American-engineered hepatitis C treatment, is currently available at the National Blood Transfusion Center (NBTC)’s public pharmacy and it can be sold to the consumers in installments, center director Hala Hussein told Youm 7 Thursday.
“The available Sovaldi is locally manufactured by Pharco Pharmaceuticals and we started selling it from today,” she said.
“We will be implementing the installment payment system in order to be affordable for the employees and middle class families,” she added.
Last week, Youm 7 reported that the Egyptian market will receive a new batch of Sovaldi locally manufactured by Pharmed Healthcare Company in June.
In September 2014, Egypt imported 225,000 bottles from the U.S., manufactured by the Gilead Science Company, and also a received a similar amount in March 2015. The sticker price for the drug is approximately $1,000 per pill in the U.S. market, with a 12-week course of treatment amounting to $84,000 according to Forbes magazine, however the manufacturer has provided stores of the medication to Egypt for a 99% discount, with Cairo subsidizing much of the remaining costs to provide treatment to its citizens.
Egypt has the highest rate of hepatitis C infection in the world, according to the United Nations Population Fund; 14.7 percent of the population ages 15-49 have tested positive for the virus.
The Ministry of Health treated 150,000 patients last year, and has stated it plans to treat 250,000 to 300,000 patients.